Skip to main content
oAv Menu
Home
Patient Care Center
Clinical Trials
Providers
Therapeutics
People
Places
Community Center
Community Stories
Social Media
Community Content
Financial Assistance
News
Community Events
Clinical Trials and Research
Business
News People
Happenings
Spotlight
Fundraising Events
Trusted Resources
Education
Videos & Visuals
Event Calendar
Login
Search
UPCOMING SESSIONS
in
ET
Wed, Apr 8, 2026
10:00 – 11:00 PM UTC
CAR-T Therapy for AL Amyloidosis: What’s New, What’s Real, and What’s Next
Heather Landau
Click To Register
View all
UPCOMING SESSIONS
in
ET
Wed, Apr 8, 2026 · 10:00 – 11:00 PM UTC
CAR-T Therapy for AL Amyloidosis: What’s New, What’s Real, and What’s Next
Heather Landau
Click To Register
View all sessions
All Upcoming Sessions
3
APR
8
CAR-T Therapy for AL Amyloidosis: What’s New, What’s Real, and What’s Next
Wed, Apr 8, 2026 · 10:00 – 11:00 PM UTC
Heather Landau
Register
APR
9
Rare and Remarkable: Turning Challenges into Purpose
Thu, Apr 9, 2026 · 10:00 – 11:00 PM UTC
Michele Wright
Register
APR
15
Newly Diagnosed ATTR Patients Onboarding Session
Wed, Apr 15, 2026 · 3:00 – 5:00 PM UTC
Dr. Stacey Goodman
Register
Birtamimab
Home
Birtamimab
Prothena Reports Results From the Phase 3 VITAL Amyloidosis Study of NEOD001 (Birtamimab) in AL Amyloidosis
Prothena Corporation PLC, a clinical-stage neuroscience company, today reported final results from the Phase 3 VITAL Amyloidosis study of NEOD001 (birtamimab) in…
Read more
Subscribe to
